Brief: Oragenics Inc Confident In Strategic Direction And Specifically in Plans To Advance N-COV2-1
30/09/2022 12:42
Sept 30 (Reuters) - Oragenics Inc OGEN.A :
* ORAGENICS INC - CONFIDENT IN OUR STRATEGIC DIRECTION AND
SPECIFICALLY IN OUR PLANS TO ADVANCE NT-COV2-1
Source text for Eikon: ID:nBw8nzJBqa
Further company coverage: OGEN.A
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Oragenics
See all newsBrief: Oragenics Reports Continued Clinical Progress, Provides Regulatory And NYSE American Listing Update
Brief: Oragenics Signs Letter Of Intent To License Cardiodialysis™ Technology From Sigyn Therapeutics To Target Tbi-Induced Systemic Inflammation
Brief: Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing
Brief: Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.
Brief: Oragenics Enters Settlement Agreement With Ladenburg Thalmann - Sec Filing